Prelude Therapeutics Incorporated - PRLD

SEC FilingsOur PRLD Tweets

About Gravity Analytica

Recent News

  • 06.11.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.11.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.05.2025 - 2025 Jefferies Global Healthcare Conference
  • 06.05.2025 - 2025 Jefferies Global Healthcare Conference
  • 06.02.2025 - Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
  • 06.02.2025 - Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
  • 05.07.2025 - Citizens Life Sciences Conference
  • 05.07.2025 - Citizens Life Sciences Conference
  • 05.06.2025 - Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
  • 05.06.2025 - Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Recent Filings

  • 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.06.2025 - EX-99.1 EX-99.1
  • 05.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.06.2025 - 8-K Current report
  • 04.29.2025 - ARS Annual Report to Security Holders
  • 04.29.2025 - DEF 14A Other definitive proxy statements
  • 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material